Gustavo Dix Junqueira Pinto

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations

Letícia Ferro Leal, Flávia Escremim de Paula, Pedro De Marchi et al. · Scientific Reports · 2019 · 48 citations · Full text

Medicine, Genetics, Oncology +15

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

Alexandre Arthur Jacinto, Eronides Salustiano Batalha Filho, Luciano de Souza Viana et al. · BMC Cancer · 2018 · 39 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

Sun Min Lim, Solange Peters, Ana Laura Ortega Granados et al. · Nature Communications · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of PD-L1 Expression in Tumor Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographic Data

Gustavo Dix Junqueira Pinto, Luciano de Souza Viana, Cristovam Scapulatempo‐Neto et al. · Journal of Immunology Research · 2016 · 20 citations · Full text

Medicine, Immunology, Oncology +17